Evidence map›Paper›PMID 40687381›Full record

ArticleJournal of hepatocellular carcinoma2025

Can Peritumoral Radiomics Based on MRI Predict the Microvascular Invasion Status of Combined Hepatocellular Carcinoma and Cholangiocarcinoma Before Surgery?

Le Guo, Chantao Huang, Peng Hao, Ningyang Jia, Ling Zhang

Abstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Le Guo *Lab of Molecular Imaging and Medical Intelligence, Department of Radiology, Longgang Central Hospital of Shenzhen (Shenzhen Clinical Medical College, Guangzhou University of Chinese Medicine), Shenzhen, 518116, People's Republic of China.
Chantao Huang *Department of Imaging Diagnosis, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.
Peng Hao *Department of Imaging Diagnosis, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.
Ningyang JiaDepartment of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, People's Republic of China.
Ling ZhangDepartment of Imaging Diagnosis, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.ORCID 0000-0002-2942-8022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the role of MRI peritumoral imaging in predicting microvascular invasion (MVI) status in patients with combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CCA). Methods: Clinical and pathological data and MRI images of 118 patients with surgically resected and pathologically confirmed cHCC-CCA were retrospectively collected. The tumor in MRI images was segmented by ITK-SNAP software in three dimensions and extended 1 centimeter(cm) towards the tumor periphery. Then, the Python open-source platform was used for radiomics analysis. Mutual information and recursive elimination methods were used to select the optimal features. Clinical models and radiomics models were constructed based on six classifiers. The model's effectiveness was comprehensively evaluated using receiver operating characteristic (ROC), area under curve (AUC), and decision curve analysis (DCA), and the model results were output using Shapley Additive exPlans (SHAP). Results: The differences in HBeAg, capsule, target sign, and lymph node metastasis between MVI negative and positive groups were statistically significant ( Conclusion: Radiomics with a 1cm extension around the tumor can improve the performance of machine-learning models in predicting MVI labels.

Indexed as

combined hepatocellular carcinoma and cholangiocarcinomamicrovascular invasionperitumoral radiomicsShapley additive explans

Identifiers

PMID40687381
PMCPMC12276744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.